Serveur d'exploration COVID et hydrochloroquine - Exploration (Accueil)

Index « Titre (en) » - entrée « suspected »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
susceptible < suspected < suspension  Facettes :

List of bibliographic references indexed by suspected

Number of relevant bibliographic references: 8.
Ident.Authors (with country if any)Title
000394 (2021) Tajamul H. MirImmune Thrombotic Thrombocytopenic Purpura (iTTP) in a Patient with Suspected COVID-19: Hydroxychloroquine Culprit or Just a Happenstance?
000497 (2021) I N Nur Sultan Öncü [Turquie] ; Dilara Güler [Turquie] ; Gülhan Gürel [Turquie]Exacerbation of psoriasis following hydroxychloroquine in a patient with suspected COVID-19.
000B86 (2020) Yu Kang ; Hui Wang ; Hong Chen ; Bo Wang ; Yingying Yang ; Xuan Zhao ; Qihui Ran ; Jiafu WeiSuspected Hydroxychloroquine-Induced Sinus Bradycardia and QTc Prolongation in a Patient with COVID-19.
000E95 (2020) Sapna A. Mehta [États-Unis] ; Jeanette Leonard [États-Unis] ; Pauline Labella [États-Unis] ; Katarzyna Cartiera [États-Unis] ; Irfana Soomro [États-Unis] ; Henry Neumann [États-Unis] ; Robert A. Montgomery [États-Unis] ; Nicole M. Ali [États-Unis]Outpatient management of kidney transplant recipients with suspected COVID-19-Single-center experience during the New York City surge.
001003 (2020) T P Afra [Inde] ; Ram Vasudevan Nampoothiri [Canada] ; Muhammed Razmi T [Inde] ; N A Bishurul Hafi [Inde]Linking hydroxychloroquine to hemolysis in a 'suspected' glucose-6-phosphate dehydrogenase deficient patient with COVID-19 infection - a critical appraisal.
001065 (2020) Elena Ramírez [Espagne] ; Mikel Urroz [Espagne] ; Amelia Rodríguez [Espagne] ; Miguel González-Mu Oz [Espagne] ; Alberto Martín-Vega [Espagne] ; Yuri Villán [Espagne] ; Enrique Seco [Espagne] ; Jaime Monserrat [Espagne] ; Jesús Frías [Espagne] ; Antonio J. Carcas [Espagne] ; Alberto M. Borobia [Espagne]Incidence of Suspected Serious Adverse Drug Reactions in Corona Virus Disease-19 Patients Detected by a Pharmacovigilance Program by Laboratory Signals in a Tertiary Hospital in Spain: Cautionary Data.
001142 (2020) Samuel M. Brown ; Ithan D. Peltan ; Brandon Webb [États-Unis] ; Naresh Kumar ; Nathan Starr [États-Unis] ; Colin Grissom ; Whitney R. Buckel ; Raj Srivastava [États-Unis] ; Estelle S. Harris ; Lindsay M. Leither ; Stacy A. Johnson ; Robert Paine ; Tom Greene [États-Unis]Hydroxychloroquine versus Azithromycin for Hospitalized Patients with Suspected or Confirmed COVID-19 (HAHPS). Protocol for a Pragmatic, Open-Label, Active Comparator Trial.
001291 (2020) Lotfollah Davoodi [Iran] ; Seyed Mohammad Abedi [Iran] ; Ebrahim Salehifar [Iran] ; Reza Alizadeh-Navaei [Iran] ; Hamed Rouhanizadeh [Iran] ; Ghasemali Khorasani [Iran] ; Seyed Jalal Hosseinimehr [Iran]Febuxostat therapy in outpatients with suspected COVID-19: A clinical trial.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidChloroV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Title.i -k "suspected" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Title.i  \
                -Sk "suspected" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    CovidChloroV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Title.i
   |clé=    suspected
}}

Wicri

This area was generated with Dilib version V0.6.38.
Data generation: Sat May 22 17:02:32 2021. Site generation: Sat May 22 17:06:52 2021